Deep inside every cell in your body, a protein called BAP1 works silently to keep cells from growing out of control. Now, scientists in Taiwan have discovered exactly how tiny mistakes in the instruction manual for this protein can silence its cancer-fighting powers.
Researchers at National Taiwan University found that removing just one single carbon atom from one specific building block of the BAP1 protein is enough to disable it. Their findings, published in the journal Nature Communications, could one day help doctors develop smarter drugs that restore the protein's ability to fight tumors.
The team, led by Professor Shang-Te Danny Hsu, studied nearly 50 different mutations in the BAP1 protein that have been linked to cancer. They used powerful imaging technology called NMR spectroscopy to watch how the protein's parts communicate with each other while it's working. What they discovered surprised them: the protein has an intricate internal communication network, with one tiny amino acid called L49 acting as the central hub that keeps everything connected.
"Proteins are not static objects—they are constantly moving and communicating internally," Professor Hsu explained. "Our study shows that even the smallest molecular change can interrupt this communication network and lead to disease."
The mutation that caught the team's attention the most is called L49V. In this mutation, just one carbon atom is removed from the L49 amino acid. That tiny change alone breaks the entire communication network inside the protein. The protein's overall shape looks almost the same under a microscope, but it no longer works properly. This discovery helps explain why BAP1 is frequently mutated in cancers like mesothelioma, uveal melanoma, and kidney cancer.
The researchers created the largest map to date showing exactly how different cancer mutations affect BAP1 at the molecular level. This map could guide scientists working on new drugs that target the protein's communication network, rather than trying to hit the active site directly.
"Understanding these hidden dynamic networks opens new opportunities for developing precision medicines that target protein function in entirely new ways," Professor Hsu said.
For patients with cancers linked to BAP1 mutations, this research offers a new way to think about treatment. Instead of just blocking (bad things), future drugs might be able to fix or bypass the broken communication lines inside the protein, potentially restoring its tumor-fighting abilities.